Related Experiment Video
Updated: Jun 25, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
The Management of Patients at High Risk of Serious COVID-19 Disease: Optimising the Patient Pathway in the Middle
Jameela Al-Salman1, Ashraf Amir2, Luke Sp Moore3
1Medicine, Arabian Gulf University, Manama, BHR.
Antiviral treatments can prevent severe COVID-19, but their use in high-risk patients varies globally. Improving healthcare professional education and patient engagement is key to optimizing care pathways and outcomes in the Middle East, Africa, and Eastern Europe.
Area of Science:
- Infectious Diseases
- Public Health
- Pharmacology
Background:
- Antiviral therapies are available for high-risk individuals to mitigate severe COVID-19 outcomes.
- National guidelines exist for COVID-19 management, yet their real-world application in clinical practice remains unclear.
- This study addresses the therapeutic management of high-risk COVID-19 patients in the Middle East, Africa, and Eastern Europe.
Purpose of the Study:
- To assess the current management of high-risk COVID-19 patients in the Middle East, Africa, and Eastern Europe.
- To understand existing practices, identify challenges, and propose strategies for improving COVID-19 care in these regions.
- To explore the role of primary care physicians and pharmacists in managing high-risk COVID-19 patients.
Main Methods:
- A regional summit of healthcare professionals (HCPs) from the Middle East, Africa, and Eastern Europe was convened in February 2023.
- Insights from the summit were augmented by a non-systematic literature search of MEDLINE and online sources (since 2020) focusing on LMICs.
- Data synthesis informed recommendations for future priorities and optimal global care pathways for high-risk COVID-19 patients.
Main Results:
- Primary care is the initial point of contact, but the role of primary care physicians (PCPs) in treatment is uncertain.
- Significant inter-country variations in care pathways exist due to differences in local practices, healthcare systems, and resources.
- HCP education is crucial for patient identification, counseling, and management; pharmacists play a key role in managing antiviral interactions.
- Patient hesitancy and misinformation contribute to delayed treatment and symptom progression, necessitating proactive patient counseling and targeted education.
Conclusions:
- Optimizing COVID-19 management for high-risk patients requires global stakeholder collaboration.
- Effective implementation of guidelines and improved patient outcomes depend on coordinated efforts.
- Addressing patient hesitancy and enhancing HCP education are critical for improving care pathways.
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...

